Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Draig Therapeutics | Jul 2026Participated | $65 MSeries B | |
Ray Therapeutics | Apr 2026Participated | $125 MSeries B | |
Third Arc Bio | Feb 2026Participated | $52 MSeries A | |
Parabilis Medicines | Jan 2026Participated | $305 MSeries F | |
Ripple | Nov 2025Participated | $500 MOther Equity | |
Veradermics | Oct 2025Participated | $150 MSeries C | |
Attovia Therapeutics | Apr 2025Participated | $90 MSeries C | |
Aviceda Therapeutics | Jan 2025Participated | $208 MSeries C | |
Beta Bionics | Nov 2024Participated | $60 MSeries E | |
Inquis Medical | Nov 2024Led | $40 MSeries B | |
Evommune | Oct 2024Participated | $115 MSeries C | |
21Shares | Oct 2024Led | $25 MOther Equity | |
Draig Therapeutics | Jul 2026Participated | $65 MSeries B | |
Ray Therapeutics | Apr 2026Participated | $125 MSeries B | |
Third Arc Bio | Feb 2026Participated | $52 MSeries A | |
Parabilis Medicines | Jan 2026Participated | $305 MSeries F | |
Ripple | Nov 2025Participated | $500 MOther Equity | |
Veradermics | Oct 2025Participated | $150 MSeries C | |
Attovia Therapeutics | Apr 2025Participated | $90 MSeries C | |
Aviceda Therapeutics | Jan 2025Participated | $208 MSeries C | |
Beta Bionics | Nov 2024Participated | $60 MSeries E | |
Inquis Medical | Nov 2024Led | $40 MSeries B | |
Evommune | Oct 2024Participated | $115 MSeries C | |
21Shares | Oct 2024Led | $25 MOther Equity |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 0 | 4 |
| Series B | 3 | 10 |
| Series C+ | 3 | 19 |
| Other Equity | 3 | 6 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Mar '21 | 1 |
| Apr '21 | 2 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 1 |
| Aug '21 | 1 |
| Sep '21 | 3 |
| Oct '21 | 1 |
| Nov '21 | 2 |
| Dec '21 | 2 |
| Jan '22 | 2 |
| Feb '22 | 2 |
| Mar '22 | 1 |
| Apr '22 | 2 |
| May '22 | 0 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 3 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 1 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 2 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 1 |
| Jan '24 | 1 |
| Feb '24 | 1 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 2 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 2 |
| Nov '24 | 2 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 36 |
| Fintech | 14 |
| Crypto & Blockchain | 9 |
| Professional Services | 4 |
| Space & Frontier Tech | 4 |
| Data, Analytics & IT | 3 |
| Consumer & Lifestyle | 2 |
| Networks, Cloud & Communication | 2 |
| Hardware & Robotics | 2 |
| AI & Machine Learning | 2 |
| Enterprise Software | 1 |
| Manufacturing | 1 |
| E-Commerce & Retail | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 2 |
| $25M-$50M | 6 |
| $50M-$100M | 10 |
| $100M-$250M | 22 |
| $250M-$500M | 7 |
| $500M-$1B | 2 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 42 |
| Europe | 4 |
| India | 2 |
| Singapore | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Janus Henderson Investors | 8 |
| RA Capital Management | 8 |
| Logos Capital | 7 |
| venBio Partners | 7 |
| Farallon Capital Management | 6 |
| Invus | 6 |
| RTW Investments | 6 |
| Soleus Capital | 6 |
| Cormorant Asset Management | 5 |
| Omega Funds | 5 |
| OrbiMed | 5 |
| Perceptive Advisors | 5 |
| Surveyor Capital | 5 |
| abrdn | 4 |
| BlackRock | 4 |
| Catalio Capital Management | 4 |
| Fidelity Management & Research Company | 4 |
| Frazier Life Sciences | 4 |
| Novo Holdings | 4 |
| Samsara BioCapital | 4 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 9 | 18% |
| Participating | 40 | 82% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 5 | 56% |
| Co-led | 4 | 44% |
Team
CEO & Portfolio Manager
Managing Director
Co-Founder
Co-Founder
Portfolio Manager